update CRM Inc. Company Profile

10:46 EDT 26th September 2017 | BioPortfolio

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the US. update CRM’s parent company, update software AG, is the leading developer of CRM products in Europe and boasts more than twenty years of CRM experience and more than 160,000 end users in more than 1,400 customers worldwide. Update software has subsidiaries in the US, Germany, Switzerland, the Netherlands, France, Hungary, the Czech Republic, and Poland, and is listed on the German stock exchange in Frankfurt am Main.

News Articles [585 Associated News Articles listed on BioPortfolio]

UPDATE – Actinium Pharmaceuticals to Host Webinar on June 12th to Update on Pivotal Phase 3 SIERRA Clinical Trial for Iomab-B

- Dr. Rajneesh Nath, a Principal Investigator and Director of the Bone Marrow Transplant and Acute Leukemia Program at Banner MD Anderson Cancer Center will discuss his perspectives on Iomab-B in p...

FDA Drug Shortages: 05/16/17 Update

Round UpsThe FDA sent an update on May 16 of the drugs that are currently in shortage.

Novartis receives approval in the EU for Cosentyx label update

Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Cosentyx® (secukinumab), the first interleukin-17A (IL-17A) approved to treat pso...

UPDATE: Argenx’s IPO soars to over €100M to prove itself in Phase II

UPDATE (22/05/2017): Argenx has gone above and beyond to secure $115M (€103M) on the NASDAQ. Underwriters claimed all of the shares offered in over allotment, bringing the IPO to 50% more than t...

Researchers publish 2017 update of SpA, PsA treatments to target

Researchers have published a 2017 update of treatments to target for patients with axial spondyloarthritis, peripheral spondyloarthritis and psoriatic arthritis.“[An] update of recommendations to tr...

Update: FDA Clears the Way to Approval for Novartis’ Key Competitor in CAR-T Race

UPDATE 08/08/2017: The FDA has cleared Kite to skip the outside advisors hearing in the approval process, signaling that Novartis’ main competitor may launch its CAR-T  therapy as early as Sept...

Siemens to issue security update for some PET scanners this month

A spokesman for Siemens said Monday that the company will release a software update for Microsoft Windows 7-based versions of -More- 

FDA Drug Shortages & Discontinuations: 05/22/17 Update

Round UpsMay 22 update: Four drugs discontinued and more than a dozen new drugs reported to be in shortage.Staff Author: 

Drugs and Medications [0 Results]


PubMed Articles [547 Associated PubMed Articles listed on BioPortfolio]

Update on tauopathies.

The purpose of this review is to provide an update on the role of tau beyond the stabilization of microtubules and on the clinical, pathological, diagnostic and therapeutic aspects of tauopathies.

Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project.

As part of the World Cancer Research Fund International Continuous Update Project, we updated the systematic review and meta-analysis of prospective studies to quantify the dose-response between foods...

Aircraft engine sensor fault diagnostics using an on-line OBEM update method.

This paper proposed a method to update the on-line health reference baseline of the On-Board Engine Model (OBEM) to maintain the effectiveness of an in-flight aircraft sensor Fault Detection and Isola...

Clinical Update: Osteoporosis Management.

The clinical update serves as a brief review of recently published, high-impact, and potentially practice changing journal articles summarized for our readers. Topics include menopause, sexual dysfunc...

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.

Non-classic congenital hyperplasia (NCAH) due to 21-hydroxylase deficiency is a common autosomal recessive disorder characterized by androgen excess.

Clinical Trials [64 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Support Annual Strain Update, Safey and Immnogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

This phase II, open label, is designed as a seasonal study to support annual strain update evaluating the safety, clinical tolerability and immunogenicity of the 2007-2008 formulation of ...

Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet

This study was an update and amplification of exposure measurements of the EPIC-Potsdam Study, which started in 1994-1998.

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) to adult patients with early manifestations of HIV disease. To assess the efficacy of AZT therapy in the tr...

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

This Phase 4, prospective, multicenter, non-interventional, regulatory post-marketing surveillance study will collect information on the the safety and effectiveness of atezolizumab under ...

Companies [46 Associated Companies listed on BioPortfolio]

update CRM Inc.

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the U...

Update AG


Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the...

The Hartford Income Shares Fund, Inc.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or b...


WHAT:2012 Annual Meeting featuring Gov. Robert Bentley, an update of the BioAlabama Five Year Strategic Plan and presentation of Biotechnology Resolution by Sen. Jabo Waggoner and...

More Information about "update CRM Inc." on BioPortfolio

We have published hundreds of update CRM Inc. news stories on BioPortfolio along with dozens of update CRM Inc. Clinical Trials and PubMed Articles about update CRM Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of update CRM Inc. Companies in our database. You can also find out about relevant update CRM Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record